[go: up one dir, main page]

ZA200805566B - 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors - Google Patents

6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors

Info

Publication number
ZA200805566B
ZA200805566B ZA200805566A ZA200805566A ZA200805566B ZA 200805566 B ZA200805566 B ZA 200805566B ZA 200805566 A ZA200805566 A ZA 200805566A ZA 200805566 A ZA200805566 A ZA 200805566A ZA 200805566 B ZA200805566 B ZA 200805566B
Authority
ZA
South Africa
Prior art keywords
cathepsin
imidazo
pyridine
inhibitors
phenyl
Prior art date
Application number
ZA200805566A
Other languages
English (en)
Inventor
Cai Jiaqiang
Rankovic Zoran
Jones Philip Stephen
Bennett David Jonathan
Cumming Lain
Gillespie Jonathan
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of ZA200805566B publication Critical patent/ZA200805566B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200805566A 2006-01-16 2008-06-25 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors ZA200805566B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06100357 2006-01-16

Publications (1)

Publication Number Publication Date
ZA200805566B true ZA200805566B (en) 2009-04-29

Family

ID=35987201

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805566A ZA200805566B (en) 2006-01-16 2008-06-25 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors

Country Status (20)

Country Link
EP (1) EP1979351B1 (xx)
JP (1) JP5203968B2 (xx)
KR (1) KR20080098484A (xx)
CN (1) CN101374838B (xx)
AR (1) AR059018A1 (xx)
AT (1) ATE463496T1 (xx)
AU (1) AU2007204311B2 (xx)
BR (1) BRPI0706570A2 (xx)
CA (1) CA2635982A1 (xx)
DE (1) DE602007005775D1 (xx)
EC (1) ECSP088654A (xx)
ES (1) ES2342021T3 (xx)
IL (1) IL192133A0 (xx)
NO (1) NO20082791L (xx)
NZ (1) NZ569296A (xx)
PE (1) PE20080003A1 (xx)
RU (1) RU2400482C2 (xx)
TW (1) TW200734338A (xx)
WO (1) WO2007080191A1 (xx)
ZA (1) ZA200805566B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200911803A (en) * 2007-07-16 2009-03-16 Organon Nv 6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
US7932251B2 (en) 2007-07-16 2011-04-26 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
WO2010071819A1 (en) * 2008-12-19 2010-06-24 Schering Corporation Bicyclic heterocyclic derivatives and methods of use thereof
TW201035094A (en) 2009-01-16 2010-10-01 Organon Nv 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
US8026236B2 (en) 2009-01-16 2011-09-27 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
US9328118B2 (en) * 2012-04-17 2016-05-03 Astellas Pharma Inc. Nitrogen-containing bicyclic aromatic heterocyclic compound
WO2016100184A1 (en) 2014-12-16 2016-06-23 Forum Pharmaceuticals, Inc. Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
JP2018516973A (ja) 2015-06-10 2018-06-28 フォーラム・ファーマシューティカルズ・インコーポレイテッドＦｏｒｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． α７−ニコチン性アセチルコリン受容体のアゴニストとしてのアミノベンゾイソオキサゾール化合物
EP3334740A4 (en) 2015-08-12 2019-02-06 Axovant Sciences GmbH GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF ALPHA 7-NICOTINIC ACETYLCHOLINE RECEPTORS
WO2020201572A1 (en) 2019-04-05 2020-10-08 Université De Bretagne Occidentale Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning
CN116514813A (zh) * 2021-12-31 2023-08-01 轩竹生物科技股份有限公司 酪氨酸激酶抑制剂及其中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU566842A1 (ru) * 1976-01-06 1977-07-30 Донецкое Отделение Физико-Органической Химии Института Физической Химии Им.Л.В.Писаржевского Ан Украинской Сср Способ получени замещенных имидазопиридинов
UA62972C2 (en) * 1997-07-03 2004-01-15 Application of imidazopyrimidins and imidazopyridins for the treatment of neural disorders
DE19845153A1 (de) * 1998-10-01 2000-04-06 Merck Patent Gmbh Imidazo[4,5]-pyridin-4-on-derivate
SE0201980D0 (sv) * 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
US20070197510A1 (en) * 2004-03-10 2007-08-23 Kazuyuki Ohmoto Nitriles and medicinal compositions containing the same as the active ingredient

Also Published As

Publication number Publication date
DE602007005775D1 (en) 2010-05-20
AR059018A1 (es) 2008-03-05
ES2342021T3 (es) 2010-06-30
JP5203968B2 (ja) 2013-06-05
AU2007204311B2 (en) 2011-07-14
PE20080003A1 (es) 2008-01-30
KR20080098484A (ko) 2008-11-10
NZ569296A (en) 2010-04-30
AU2007204311A1 (en) 2007-07-19
ATE463496T1 (de) 2010-04-15
AU2007204311A8 (en) 2008-07-31
JP2009523717A (ja) 2009-06-25
CN101374838B (zh) 2013-04-03
CA2635982A1 (en) 2007-07-19
RU2400482C2 (ru) 2010-09-27
IL192133A0 (en) 2008-12-29
RU2008133588A (ru) 2010-02-27
CN101374838A (zh) 2009-02-25
EP1979351B1 (en) 2010-04-07
ECSP088654A (es) 2008-08-29
EP1979351A1 (en) 2008-10-15
BRPI0706570A2 (pt) 2011-04-05
TW200734338A (en) 2007-09-16
NO20082791L (no) 2008-10-14
WO2007080191A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
ZA200805566B (en) 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors
PL2074122T3 (pl) Związki pirydo(2,3-D)pirymidynonowe i ich zastosowanie jako inhibitory PI3
IL184901A0 (en) 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
PT2094263E (pt) Derivados da 2-adamantil-butiramida como inibidores seletivos da 11-beta-hsd1
ZA200909132B (en) 6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile derivatives as cathepsin inhibitors
ZA200702394B (en) Indozolone derivatives as 11b-HSD1 inhibitors
EP1999130A4 (en) Pyridopyrimidine derivatives and their use as PDE4 inhibitors
PL2081929T3 (pl) Podstawione związki 3-izobutylo-9,10-dimetoksy-1,3,4,6,7,11b-heksahydro-2H-pirydo[2,1-a]izochinolin-2-olowe i ich wytwarzania
ZA200700181B (en) Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
ZA200903160B (en) Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL198509A0 (en) Azaindole derivatives, compositions containing the same and uses thereof
PL2046797T3 (pl) Pochodne furo-[3,2-b]pirol-3-onu i ich zastosowanie jako inhibitorów proteinaz cysteinowych
IL198462A0 (en) Diazepane-acetamide derivatives as selective 11??-hsd1 inhibitors
PL2057153T3 (pl) POCHODNE (3-ARYLO-PIPERAZYN-1-YLOWE) 6,7-DIALKOKSYCHINAZOLINY, 6,7-DIALKOKSYFTALAZYNY i 6,7-DIALKOKSYIZOCHINOLINY
IL195915A0 (en) 3-amino -imidazo[1,2-a]pyridine derivatives as sglt inhibitors
ZA200807809B (en) Substituted chromanol derivatives and their use
ZA200706672B (en) 2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors
IL192427A0 (en) Derivatives of sulindac, use thereof and preparation thereof
AU2006321904A8 (en) 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
AP2008004470A0 (en) Spirocyclic quinazoline derivatives as pde7 inhibitors
ZA200810629B (en) Phenylpentadienoyl derivatives and their use as par 1 antagonists
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL194873A0 (en) Methods for reducing 7/9-nitrotetracycline derivatives
IL194737A0 (en) 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof